COVER STORY•封面專題 2020 UMAGAZINE 22•澳大新語 22 Faculty of Health Sciences Associate Professor Di Lijun and his team have discovered, through meta-analysis, that supplementing estrogen (hormone replacement therapy, or HRT) to ovarian cancer patients with ovariectomy (surgical removal of one or both ovaries) may help improve the effectiveness of chemotherapy and make recurrence less likely. To some extent, this finding is distinct from conventional assumptions of ovarian cancer therapy. 健康科學學院副教授狄利俊團隊透過元分析發現，為做過卵巢切除手術的卵巢癌 患者補充雌激素（激素替代療法）有助於提升化療效果及減低復發風險，該研究 結果一定程度上顛覆了以往醫學界對卵巢癌治療的觀點。 以激素替代療法 與化療法相結合治療卵巢癌 Combining Hormone Replacement Therapy with Chemotherapy for Ovarian Cancer Treatment 文/盛惠怡‧圖/編輯部，部分由受訪者提供 Chinese & English Text / Debby Seng ‧ Photo / Editorial Board with some provided by the interviewee 狄利俊教授團隊的 研究一定程度上顛覆 了以往醫學界對卵巢 癌治療的觀點 To some extent, the finding of Prof Di Lijun’s research is distinct from conventional assumptions of ovarian cancer therapy
RkJQdWJsaXNoZXIy MTQ1NDU2Ng==